Chugai Pharmaceutical retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $10.032B, a 50.75% increase year-over-year.
Chugai Pharmaceutical retained earnings (accumulated deficit) for 2023 were $10.57B, a 6.14% increase from 2022.
Chugai Pharmaceutical retained earnings (accumulated deficit) for 2022 were $9.959B, a 3.83% increase from 2021.
Chugai Pharmaceutical retained earnings (accumulated deficit) for 2021 were $9.592B, a 20.18% increase from 2020.